Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus

NCT01951274 is registered in ClinicalTrials.gov with Vyne Therapeutics Inc. as lead sponsor.

NCT NCT01951274
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01951274 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Lead sponsor
Vyne Therapeutics Inc.
Phase
Phase 2
Overall status
Completed
Start date
October 15, 2013
Completion date
December 2, 2014
Enrollment
257 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

chronic pruritus